[ccpw id="5"]

Home.forex news reportIs Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to...

Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now?

-


Evotec SE (NASDAQ:EVO) is one of the best debt-free penny stocks to buy right now. On January 8, the company’s Seattle-based subsidiary Just-Evotec Biologics received a new grant from the Gates Foundation. The grant is to be used to enable global access to the company’s biotherapeutics utilizing Evotec Biologics’ molecular design suite.

Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now?
Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now?

Copyright: nexusplexus / 123RF Stock Photo

The Gates Foundation grant is also part of an effort to improve the development and reduce the cost of monoclonal antibodies. The ultimate goal is to make them affordable and accessible to prevent infectious disease in low and middle-income countries.

The grant comes on the heels of reports that Evotec is poised to benefit from Amgen’s Dark Blue Acquisition. As one of the early collaborators and investors in Oxford-based Dark Blue, the company is entitled to some proceeds from the transaction. The transaction carries a potential value of up to $840 million. Evotec has been involved in the development and expansion of Dark Blue’s technology platform and holds an equity stake of about 20%.

“Evotec welcomes Amgen’s acquisition of Dark Blue Therapeutics – a company that originally emerged as a pre-seed project within LAB282, the first collaboration in Evotec’s Academic BRIDGE portfolio,” company spokesperson Dr Sarah Fakir told the editorial staff on request. “In line with our shareholding, we have received a portion of the fixed upfront payment and see potential additional upside linked to the achievement of defined development milestones.”

Evotec SE (NASDAQ:EVO) is a global life sciences company that pioneers drug discovery and development, leveraging cutting-edge science, technology, and AI to accelerate the development of new medicines for pharma, biotech, and academia.

While we acknowledge the potential of EVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Blue Chip Stocks to Buy for 2026 and 10 Best Metal Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

2 Monster Stocks in the Making to Buy and Hold

Investing in companies that are about to experience accelerating growth can set you up for monster returns in the stock market. It's even better...

1 Top Dividend Stock to Buy With Double-Digit Dividend Growth and an Aggressive Share Repurchase Program

American Express (AMEX) has increased its dividend by 90% in the past five years. AMEX's business...

Artificial Intelligence Needs Nuclear Energy, and Oklo Could Deliver It

Oklo is designing a small nuclear reactor that can supply enough power to keep a large...

What’s the Better Total Market ETF Buy?

The Vanguard Total Stock Market ETF (VTI) and the iShares Core S&P Total U.S. Stock Market ETF...

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img